Circulating Levels of WISP-1 (Wnt1-Inducible Signaling Pathway Protein 1) and Other Selected Adipokines in Children With Inflammatory Bowel Disease

Role of Adipose Tissue in Inflammatory Bowel Disease

(2021) Eva Karaskova et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Plasma asprosin, CCDC80 and ANGPTL4 levels are associated with metabolic and cardiovascular risk in patients with inflammatory bowel disease

(2021) Hao-Hua Wang et al.   PHYSIOLOGICAL RESEARCH

The Assessment of Plasma Fatty Acid Profiles in Newly Diagnosed Treatment-Naïve Paediatric Crohn’s Disease

(2021) J SCHWARZ et al.   PHYSIOLOGICAL RESEARCH

Serum adipokines as non-invasive biomarkers in Crohn’s disease

(2020) Lorena Ortega Moreno et al.   Scientific Reports

Wnt signaling in intestinal inflammation

(2019) Lavanya Moparthi et al.   DIFFERENTIATION

A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis

(2019) Kathryn A. Murray et al.   PLoS One

The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease

(2019) Eder et al.   Cells

Plasma Levels of Retinol Binding Protein 4 Relate to Large VLDL and Small LDL Particles in Subjects with and without Type 2 Diabetes

(2019) Hanna Wessel et al.   Journal of Clinical Medicine

Adipokines and Their Role in Intestinal Inflammation

(2018) Carl Weidinger et al.   Frontiers in Immunology

The official unified nomenclature adopted by the HGNC calls for the use of the acronyms, CCN1–6, and discontinuation in the use of CYR61, CTGF, NOV and WISP 1–3 respectively

(2018) Bernard Perbal et al.   Journal of Cell Communication and Signaling

Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling

(2017) Miguel Quiros et al.   JOURNAL OF CLINICAL INVESTIGATION

Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?

(2017) Resul Kahraman et al.   Therapeutics and Clinical Risk Management

Assessment of circulating Wnt1 inducible signalling pathway protein 1 (WISP-1)/CCN4 as a novel biomarker of obesity

(2017) Christopher Tacke et al.   Journal of Cell Communication and Signaling

Dual effect of WISP-1 in diverse pathological processes

(2016) Mengmeng Feng et al.   Chinese Journal of Cancer Research

WISP1 Is Increased in Intestinal Mucosa and Contributes to Inflammatory Cascades in Inflammatory Bowel Disease

(2016) Qi Zhang et al.   DISEASE MARKERS

Interaction of obesity and inflammatory bowel disease

(2016) Jason W Harper et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Metabolic Inflammation in Inflammatory Bowel Disease

(2015) Pedro Gonçalves et al.   INFLAMMATORY BOWEL DISEASES

WISP1 Is a Novel Adipokine Linked to Inflammation in Obesity

(2014) Veronica Murahovschi et al.   DIABETES

Impact of Abdominal Visceral Adipose Tissue on Disease Outcome in Pediatric Crohnʼs Disease

(2014) Victor Uko et al.   INFLAMMATORY BOWEL DISEASES

Serum adipokines in inflammatory bowel disease

(2014) Marek Waluga   WORLD JOURNAL OF GASTROENTEROLOGY

The Emerging Role of Leptin Antagonist as Potential Therapeutic Option for Inflammatory Bowel Disease

(2013) Udai P. Singh et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

The ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents

(2013) Arie Levine et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn’s disease and ulcerative colitis

(2013) Giorgos Chouliaras et al.   PEDIATRIC RESEARCH

Retinol-Binding Protein 4 Is an Independent Factor Associated With Triglycerides and a Determinant of Very Low-Density Lipoprotein–Apolipoprotein B100 Catabolism in Type 2 Diabetes Mellitus

(2012) Bruno Vergès et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn's disease

(2012) V. S. Rodrigues et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Use of immunomodulators and biologic therapies in children with inflammatory bowel disease

(2010) Athos Bousvaros   Expert Review of Clinical Immunology

Appraisal of the pediatric ulcerative colitis activity index (PUCAI)

(2009) Dan Turner et al.   INFLAMMATORY BOWEL DISEASES

Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohnʼs disease

(2009) Johanna Weigert et al.   INFLAMMATORY BOWEL DISEASES

Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease

(2008) Luzia Valentini et al.   NUTRITION